home / stock / adk:cc / adk:cc news

ADK:CC News and Press, Diagnos Inc. From 10/05/23

Stock Information
Company Name: Diagnos Inc.
Stock Symbol: ADK:CC
Market: TSXVC
Website: diagnos.ca
Menu
ADK:CC ADK:CC Quote ADK:CC Short ADK:CC News ADK:CC Articles ADK:CC Message Board
Get ADK:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
ADK:CC - DIAGNOS AI Retina Analysis is being deployed across Canada's Largest Specialist Care Provider in Diabetes & Endocrinology

BROSSARD, Quebec, Oct. 05, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ” or the “ Corporation ”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian corporation active in early detection of critical health issues through the use of its FL AI RE platform base...
ADK:CC - DIAGNOS Announces Closing of Private Placement and Exercise of Stock Warrants

BROSSARD, Quebec, May 18, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a Canadian corporation active in early detection of critical health issues through the use of its FL AI RE platform based on Artifici...

ADK:CC - DIAGNOS and IRIS, The Visual Group strengthen partnership with the launch of "IRIS-ai powered by DIAGNOS"

BROSSARD, Quebec, May 17, 2023 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform based o...

ADK:CC - DIAGNOS and ÉTS Unveil a Method to Adapt Deep Learning Algorithms According to the Diversity of Contexts

BROSSARD, Quebec, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is one of the leaders in early detection of critical health issues through the use of its FLAIRE platform based on Ar...
ADK:CC - DIAGNOS and ETS to Present Ground-breaking Research on Mass Screening for Macular Edema at ARVO 2023

BROSSARD, Quebec, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“DIAGNOS”, the “Corporation” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) is a leader in early detection of critical health issues through the use of its FLAIRE platform based on Artificial I...

ADK:CC - DIAGNOS Announces Grant of Stock Options

BROSSARD, Quebec, Feb. 10, 2023 (GLOBE NEWSWIRE) -- February 10, 2023 – Diagnos Inc. (“DIAGNOS” or “the Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FL AI RE platform based...

ADK:CC - DIAGNOS Gets the Green Light for the Use of its Diabetic Retinopathy Screening Technology in Quebec Hospitals

BROSSARD, Quebec, Jan. 31, 2023 (GLOBE NEWSWIRE) -- Diagnos Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform based ...
ADK:CC - DIAGNOS Provides Additional Information to the Closing of Private Placement

BROSSARD, Quebec, Dec. 15, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FL AI RE platform based on Artificial Intelligence ( ...

ADK:CC - DIAGNOS Enters the Retinal Diagnostics Market With its New 3D Image Analysis Technology

BROSSARD, Quebec, Oct. 27, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“ DIAGNOS ”, the “ Corporation ” or ”we”) (TSX Venture: ADK) (OTCQB: DGNOF) a leader in early detection of critical health issues through the use of its FL AI RE platform ...

ADK:CC - DIAGNOS Announces Closing of Private Placement

BROSSARD, Quebec, Sept. 01, 2022 (GLOBE NEWSWIRE) -- DIAGNOS Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK) (OTCQB: DGNOF), a leader in early detection of critical health issues through the use of its FL AI RE platform based on Artificial Intelligen...
Previous 10 Next 10